Pancreatic Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Pancreatic Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-01-03Clinical Trial Update: Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas [Phase 3]
Phase 3 trial comparing FFX to CPI-613 with mFFX in metastatic pancreatic adenocarcinoma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer [NA]
A clinical trial evaluating a radiopaque hydrogel used during radiotherapy for pancreatic adenocarcinoma has completed, and results have bee…
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Role of Interim 18F-FLT PET/CT for Outcome Prediction in Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial evaluating interim 18F-FLT PET/CT to predict outcomes in pancreatic adenocarcinoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Neoadjuvant Modified FOLFIRINOX and Stereotactic Body Radiation Therapy in Borderline Resectable Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial update on neoadjuvant modified FOLFIRINOX with stereotactic body radiation therapy in borderline resectable pancreatic adenoca…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Study of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PAC [Phase 3]
Phase 3 study evaluating Eryaspase plus chemotherapy versus chemotherapy alone as second-line treatment for pancreatic adenocarcinoma has co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma [Phase 1, Phase 2]
Phase 1/2 trial assessing APX005M with gemcitabine and nab-paclitaxel, with or without nivolumab, in previously untreated metastatic pancrea…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors [Phase 2, Phase 3]
Phase 2/3 trial evaluating survival after neoadjuvant therapy in patients with resectable pancreatic cancer and risk factors. Status is unkn…
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Locally Advanced or Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 clinical trial update for locally advanced or metastatic pancreatic adenocarcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-24Clinical Trial Update: Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy with or without hypofractionated radiation therapy before surgery for pancreatic cancer; s…
-
CLINICAL_TRIALS trial_result · 2022-03-07Clinical Trial Update: Neoadjuvant Chemotherapy for Pancreatic Cancer Followed by GS and GnP [Phase 2, Phase 3]
A neoadjuvant chemotherapy trial for pancreatic adenocarcinoma combining GS and GnP is in Phase 2/Phase 3 and currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-02-17Clinical Trial Update: PEN-866 in Patients With Advanced Solid Malignancies [Phase 1, Phase 2]
Clinical trial update for PEN-866 across multiple phases investigating advanced solid malignancies, including endometrial adenocarcinoma and…
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors [Phase 1]
Phase 1 trial evaluating LMB-100 with tofacitinib in previously treated mesothelin-expressing solid tumors, including pancreatic adenocarcin…
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer [Phase 3]
A Phase 3 trial comparing AG versus mFOLFIRINOX as neoadjuvant therapy for borderline resectable and locally advanced pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2022-01-04Clinical Trial Update: Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma [Phase 3]
A Phase 3 trial comparing adjuvant chemotherapy with gemcitabine versus mFOLFIRINOX in resected pancreatic adenocarcinoma has completed enro…
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Clinical Trial to Investigate Safety, Tolerability and MTD for SCO-101 in Combination With Gemcitabine and Nab-paclitaxel in Inoperable Pancreatic Cancer Patients. [Phase 1, Phase 2]
A clinical trial update investigating safety, tolerability, and maximum tolerated dose of SCO-101 in combination with gemcitabine and nab-pa…
-
CLINICAL_TRIALS trial_result · 2021-11-24Clinical Trial Update: SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma [NA]
Clinical trial investigating SBRT after pancreatic adenocarcinoma resection with close or positive margins; the study is completed with resu…
-
CLINICAL_TRIALS trial_result · 2021-11-08Clinical Trial Update: A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma [Phase 2]
Phase 2 pilot study examining pre- and post-surgery mFOLFIRINOX chemotherapy in patients with localized, resectable pancreatic adenocarcinom…
-
CLINICAL_TRIALS trial_result · 2021-10-04Clinical Trial Update: A Phase 2 Trial of Neoadjuvant Modified FOLFIRINOX Chemotherapy for Resectable Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial update of neoadjuvant modified FOLFIRINOX for resectable pancreatic adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Phase II/III of Randomized Controlled Clinical Research on IRE Synchronous Chemotherapy for LAPC [Phase 2, Phase 3]
A randomized Phase II/III trial evaluating irreversible electroporation (IRE) with synchronous chemotherapy for locally advanced pancreatic …
-
CLINICAL_TRIALS trial_result · 2021-08-16Clinical Trial Update: Anlotinib, Toripalimab and Nab-paclitaxel in Locally Advanced/Metastatic Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating anlotinib, toripalimab, and nab-paclitaxel for locally advanced or metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Geriatric Assessment Directed Trial to Evaluate Gemcitabine +/- Nab-paclitaxel in Elderly Pancreatic Cancer Patients [Phase 4]
Phase 4 trial update evaluating gemcitabine with or without nab-paclitaxel in elderly pancreatic cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: A Study of Nal-IRI With 5-FU, Levofolinic Acid and Oxaliplatin in Patients With Resectable Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for Nal-IRI with 5-FU, Levofolinic acid, and Oxaliplatin in patients with resectable pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2021-07-23Clinical Trial Update: S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery [Phase 2]
Phase 2 clinical trial update evaluating combination chemotherapy or gemcitabine hydrochloride and paclitaxel albumin-stabilized nanoparticl…
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas [Phase 1, Phase 2]
Clinical trial update for M7824 (MSB0011359C) in combination with gemcitabine in adults with previously treated advanced pancreatic adenocar…
-
CLINICAL_TRIALS trial_result · 2021-05-28Clinical Trial Update: Gemcitabine and Nab-Paclitaxel vs Gemcitabine, Nab-Paclitaxel, Durvalumab and Tremelimumab as 1st Line Therapy in Metastatic Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial comparing Gemcitabine and Nab-Paclitaxel with vs without Durvalumab and Tremelimumab as first-line therapy for metastatic panc…